Observe the therapeutic efficacy of human menopausal gonadotropin combining with human chorionic gonadotropin in adolescent boys with congenital hypogonadotropic hypogonadism.
Observe safety and efficacy of human menopausal gonadotropin and human chorionic gonadotropin treating congenital hypogonadotropic hypogonadism in teenagers; which as clinic recommendation, may provide clinical basis for establishing standard treatment guideline in the future. Establish technological process and follow-up precept for human menopausal gonadotropin and human chorionic gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers. And find safety and effective dose for teenagers.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Human Menopausal Gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers
Human Chorionic Gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers
Beijing Children's Hospital
Beijing, Beijing Municipality, China
RECRUITINGtesticular volume
Time frame: Change from Baseline testicular volume at 3 months after treatment
The levels of testosterone serum (It were measured with chemiluminescent immunoassay Elecsys)
Time frame: Testosterone changes from 3 months onwards after treatment compared to pretreatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.